No Data
No Data
Asahi Net, Wacoal HD, etc. (addition) Rating
Upgrade - Bullish code | Stock name | Securities company | Previous | After the change | ------ | ----------- | ---------- | -------------- | -------------- | <4188> | Mitsubishi Chemical G | SMBC Nikko | "2" | "1" | Downgrade - Bearish code | Stock name | Securities company | Previous | After the change | ------ | -------
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
List of buying conversion brands in the market Code: Brand name, closing price, SAR Tokyo Stock Exchange Prime <1786>: Oriental Shirai, 357, 337 <1884> Nichi-doro: 1811, 1699 <1951> Exio G: 1573, 1543 <2695> Kura Sushi: 4435, 4170 <2742> Hellos: 4340
There is a growing trend to search for cars that will replace SUVs.
Due to the socio-economic changes caused by the Oil Crisis and new emission regulations in the 1970s, a trend of switching from large, gas-guzzling cars to smaller and more fuel-efficient Japanese cars emerged in the USA. As a result, automobile designers, manufacturer executives, and analysts are reportedly focusing on the big question of "what comes after SUVs". <7203> Toyota <6758> Sony Group Corp
Three key points to watch in the morning session - movements aimed at rebounding technology stocks.
In the morning session on the 18th, the following three points are worth noting: ■ Movement aimed at rebounding high-tech stocks ■ San-ou-tatsu, operating profit of 240 million yen, down 14.3% on April 24th, expected to increase by 42.3% to 350 million yen on April 25th. ■ Morning focus: Canon, Toyota, and other 49 companies and organizations aim to establish a cross-sectoral management foundation for chemical substances, and aim to operate it from 27 years onward. On the 18th, the Japanese stock market is likely to develop into a strong market with a sense of stagnation after a round of buying. In the US market on the 17th
Canon Inc., Suzuki, and others [List of stock information from newspapers]
*Canon Inc-Spons ADR<7751>, Toyota and 49 other organizations aim to create a cross-sector management framework for chemical substances and plan to operate it for 27 years (Nikkan Kogyo front page)-○*Nittoku<6145> opens new factory in Miyagi with a production line dedicated to EV motors (Nikkan Kogyo front page)-○*Suzuki<7269> partners with Tier IV to develop self-driving car services (Nikkan Kogyo page 3)-○*SoftBank G<9984> partners with US start-up and offers 1-year free use of AI search engine (Nikkan Kogyo page 4)-○*Hokkaido Electric Utilities<9509>, Mitsubishi...
Regarding the transfer of Alagatrobhan business in Europe. NEW
Takeda Mitsubishi Pharmaceuticals Co., Ltd. (headquarters: Chuo-ku, Osaka; President: Akihiro Tsujimura; hereinafter referred to as "Takeda Mitsubishi Pharma"), a subsidiary of Mitsubishi Chemical Holdings Group, has signed an agreement on June 13 to transfer the selective anti-thrombin agent "Argatroban hydrate" (hereinafter referred to as "Argatroban") business in Europe to Ethypharm (headquarters: Paris, France; CEO: Denis Delval; hereinafter referred to as "Ethypharm"). The company's ALS treatment drug "R" in the European operation.
No Data